Nelson Rodrigues

Researcher/clinician in the Mood Disorders Psychopharmacology Unit at the University Health Network and University of Toronto

Data updated

Papers

11 publications

Trials

0 clinical trials

Research Footprint

Nelson Rodrigues appears in 11 tracked papers (2018–2023), most studied alongside Ketamine, Psilocybin and Esketamine, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.

Most-cited paper: The hidden therapist: evidence for a central role of music in psychedelic therapy (270 citations).

Frequent co-authors: Maria Rodrigues, Roger McIntyre and Jonathan Rosenblat.

Background & Research

Nelson B. Rodrigues is a researcher associated with the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto and the University of Toronto. His published work centers on ketamine and other rapid-acting treatments for mood disorders, with interests spanning suicidality, treatment response, sleep, and real-world outcomes. He has coauthored systematic reviews and clinical studies on ketamine/esketamine in depression and related psychiatric conditions.

Key Impact

He is a recurring author on ketamine and esketamine studies, including systematic reviews and real-world clinical effectiveness research relevant to suicidality and treatment-resistant depression.

11

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

28 collaborators· click a node to visit their profile

Full network →

Compounds

KetaminePsilocybinEsketamineMDMA

Topics

Depressive DisordersTreatment-Resistant Depression (TRD)SuicidalityAnxiety DisordersMajor Depressive Disorder (MDD)Bipolar DisorderAdolescentsHealthy VolunteersSafety & Risk ManagementMedicinal Chemistry & Drug DevelopmentBorderline Personality Disorder (BPD)Personality DisordersPublic Health, Prevention & Behaviour ChangeEquity and EthicsNeurocognitive DisordersChronic PainHealth Economics & ReimbursementSchizophreniaNeuroimaging & Brain MeasuresPTSDObsessive-Compulsive Disorder (OCD)Substance Use Disorders (SUD)Set & SettingPersonality & Trait Factors

Top Collaborators

Affiliations

Institutions, companies, and organisations Nelson Rodrigues is associated with.

University Health Network, Toronto

Toronto's largest research hospital network and home to the Nikean Psychedelic Psychotherapy Research Centre — Canada's first dedicated psychedelic research centre, funded by a $5 million donation. Led by Dr. Emma Hapke, UHN's centre conducts psilocybin-assisted therapy trials for cancer patients and body dysmorphic disorder, alongside MDMA research for PTSD.

View stakeholder →

University of Toronto

University of Toronto is a leading Canadian research university whose psychedelic and psychiatric research spans the Department of Psychiatry, University Health Network collaborations, and specialized clinical units including mood-disorders psychopharmacology programs.

View stakeholder →